DOXAmdocs Limited

$62.27

DOX as reported

Amdocs Limited reported $5.00B of revenue over the trailing twelve months, +20% on the year before. 11 reported series are charted on this page, each one as filed.

$5.00B

Revenue, trailing twelve months · to FY2024 · +20% against the twelve months before

Net Income
$493M

Net Income · −0.93% year on year · trailing twelve months to FY2024

Free Cash Flow
$619M

Free Cash Flow · trailing twelve months to FY2024

Op Margin
13%

Op Margin · trailing twelve months to FY2024

Every series Ryufin has for DOX, trailing twelve months
SeriesLatestYear on yearAs of
Revenue$5.00B+20%FY2024
Net Income$493M−0.93%FY2024
EPS$4.25+15%FY2024
Gross Margin35%n/aFY2024
Op Margin13%n/aFY2024
Net Margin9.9%n/aFY2024
ROE14%n/aFY2024
ROA7.7%n/aFY2024
ROIC14%n/aFY2024
Free Cash Flow$619Mn/aFY2024
P/E14.7n/atoday

Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.

Revenue & ProfitAmdocs Limited (DOX)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com